Gapping down
In reaction to earnings/guidance:
- ABM -3.8%, WOR -2.9%, NAV -0.6%, BE -0.5% (guidance), MLHR -0.4%,
Other news:
- TRIT -17.7% (was informed that a statutory demand for payment from Antanium Resources was filed by a creditor)
- LQDA -6.9% (files for $200 mln mixed securities shelf offering)
- RRD -6.7% (says it's not currently engaged in discussions to sell its printing and packaging business in Asia Pacific)
- ZYNE -5.5% (provides regulatory update on Zygel in Fragile X Syndrome)
- GMDA -4.9% (launches follow-on offering of its ordinary shares; no terms have been disclosed)
- PRPH -4.7% (gave notice to A.G.P./Alliance Global Partners of its election to terminate the Sales Agreement dated September 23, 2020)
- PHAT -4.4% (prices offering of 2.25 mln shares of common stock at $42.00 per share)
- AUPH -3.1% (to collaborate with Otsuka Pharmaceutical for the development and commercialization of Voclosporin in Europe and Japan)
- UCTT -2% (to acquire Ham-Let)
- LXRX -1% (enters into collaboration with AC Bioscience),
Analyst comments:
- GSX -2.2% (downgraded to Neutral from Buy at UBS)
- CCJ -0.7% (downgraded to Underperform from Sector Perform at RBC Capital Mkts),